Monday, December 12, 2016

BRIEF-Gamida Cell informs Elbit that FDA clears Gamida Cell to begin Phase 3 Nicord study enrolment

* Gamida Cell informed Co that Gamida Cell has been cleared

by FDA to begin enrolling for Phase 3 study of Nicord

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)